Back to Orbis Allan Gray Ltd Orbis Allan Gray Ltd

ELVELV

Showing 8 of 30 quarters

Position history for Orbis Allan Gray LtdOrbis Allan Gray Ltd's holdings in Elevance Health, Inc.

Yes. Orbis Allan Gray holds 183,191 shares of ELV (Elevance Health), worth $70.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Orbis Allan Gray has held ELV in every 13F on record since Q1 2019, 30 quarterly filings. ELV is 0.2% of Orbis Allan Gray's reported 13F portfolio.

Current Value

$70.8M

Current Shares

183,191

Total Value Change

-$399.7M

Total Shares Change

-721,706

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
183,191
0.0%
$70.8M0.2%$385.05
0
2026-Q1
Decreased
183,191
-85.3%
$53.6M0.2%$290.30
0
2025-Q4
Decreased
1.2M
-4.8%
$436.4M1.8%$345.49
0
2025-Q3
Decreased
1.3M
-54.2%
$422.7M1.8%$316.82
0
2025-Q2
Increased
2.9M
+0.2%
$1.1B5.4%$379.31
62
2025-Q1
Increased
2.8M
+31.4%
$1.2B7.1%$422.30
79
2024-Q4
Increased
2.2M
+139.7%
$800.1M4.3%$356.67
94
2024-Q3
Decreased
904,897
-2.1%
$470.5M2.5%$500.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used